Correlation Between Cns Pharmaceuticals and Ambrx Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cns Pharmaceuticals and Ambrx Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cns Pharmaceuticals and Ambrx Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cns Pharmaceuticals and Ambrx Biopharma American, you can compare the effects of market volatilities on Cns Pharmaceuticals and Ambrx Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cns Pharmaceuticals with a short position of Ambrx Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cns Pharmaceuticals and Ambrx Biopharma.

Diversification Opportunities for Cns Pharmaceuticals and Ambrx Biopharma

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Cns and Ambrx is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Cns Pharmaceuticals and Ambrx Biopharma American in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ambrx Biopharma American and Cns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cns Pharmaceuticals are associated (or correlated) with Ambrx Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ambrx Biopharma American has no effect on the direction of Cns Pharmaceuticals i.e., Cns Pharmaceuticals and Ambrx Biopharma go up and down completely randomly.

Pair Corralation between Cns Pharmaceuticals and Ambrx Biopharma

If you would invest  1,573  in Ambrx Biopharma American on September 2, 2024 and sell it today you would earn a total of  0.00  from holding Ambrx Biopharma American or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy1.56%
ValuesDaily Returns

Cns Pharmaceuticals  vs.  Ambrx Biopharma American

 Performance 
       Timeline  
Cns Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cns Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Ambrx Biopharma American 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ambrx Biopharma American has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Ambrx Biopharma is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Cns Pharmaceuticals and Ambrx Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cns Pharmaceuticals and Ambrx Biopharma

The main advantage of trading using opposite Cns Pharmaceuticals and Ambrx Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cns Pharmaceuticals position performs unexpectedly, Ambrx Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ambrx Biopharma will offset losses from the drop in Ambrx Biopharma's long position.
The idea behind Cns Pharmaceuticals and Ambrx Biopharma American pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets